Renovorx Stock Odds of Future Stock Price Finishing Over 1.41
| RNXT Stock | USD 1.11 0.14 11.20% |
RenovoRx |
RenovoRx Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of RenovoRx for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for RenovoRx can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| RenovoRx is way too risky over 90 days horizon | |
| RenovoRx may become a speculative penny stock | |
| RenovoRx appears to be risky and price may revert if volatility continues | |
| RenovoRx has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (10.23 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| RenovoRx currently holds about 10.77 M in cash with (10.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.19, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| RenovoRx has a frail financial position based on the latest SEC disclosures |
RenovoRx Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of RenovoRx Stock often depends not only on the future outlook of the current and potential RenovoRx's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. RenovoRx's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 10.3 M | |
| Cash And Short Term Investments | 1.2 M |
RenovoRx Technical Analysis
RenovoRx's future price can be derived by breaking down and analyzing its technical indicators over time. RenovoRx Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of RenovoRx. In general, you should focus on analyzing RenovoRx Stock price patterns and their correlations with different microeconomic environments and drivers.
RenovoRx Predictive Forecast Models
RenovoRx's time-series forecasting models is one of many RenovoRx's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary RenovoRx's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about RenovoRx
Checking the ongoing alerts about RenovoRx for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for RenovoRx help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| RenovoRx is way too risky over 90 days horizon | |
| RenovoRx may become a speculative penny stock | |
| RenovoRx appears to be risky and price may revert if volatility continues | |
| RenovoRx has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (10.23 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| RenovoRx currently holds about 10.77 M in cash with (10.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.19, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| RenovoRx has a frail financial position based on the latest SEC disclosures |
Additional Tools for RenovoRx Stock Analysis
When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.